Low-dose naltrexone (LDN), a drug used to treat opioid addiction, is getting a lot of attention as an off-label treatment for multiple sclerosis ( MS)—namely, for the reduction of symptoms and relapses. It's a popular treatment among MS patients, but scientific evidence supporting its use is just...